Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine dose comparison for painless gastroenteroscopy anesthesia
ChiCTR2500100552Phase 4Completed
- Sponsor
- Deyang People's Hospital
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine in None (2 arms), sponsored by Deyang People's Hospital. Primary endpoint: Total consumption of propofol. Started Apr 2025; status: completed.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2500100552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100552.